1Suppliers
0Customers
2Debt Items
20Related Chains

Aardvark Therapeutics, Inc. Suppliers

TickerNameConfidenceEvidence
PIPER-SANDLER-CO PIPER-SANDLER-CO 90% The Company has agreed in the Equity Distribution Agreement to provide indemnification and contribution to the Agent against certain liabilities, including liabilities under the Securities Act of 193…

Aardvark Therapeutics, Inc. Customers

No clients on recordNo downstream customers found in our database for Aardvark Therapeutics, Inc..

Aardvark Therapeutics, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
AARD-DEBT-7408 Xbrl Convertible 90% xbrl convertible detail from xbrl 2025-12-31.
AARD-DEBT Debt stack $336,000 90% Market cache reports total debt of $336,000.

Aardvark Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Aardvark Therapeutics, Inc..

Aardvark Therapeutics, Inc. Ownership

HolderNameConfidenceEvidence
AARD-OWNER-DECHENG-CAPITAL-LLC Decheng Capital LLC 90% 13F overlay lists Decheng Capital LLC as top holder; 80 tracked holders.

Aardvark Therapeutics, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
MPLT MapLight Therapeutics, Inc. 100.00 2
SNYNF Sanofi 100.00 2
MCK McKesson Corporation 100.00 2
LXEO Lexeo Therapeutics, Inc. 100.00 2
A Agilent Technologies, Inc. 100.00 2
COLL Collegium Pharmaceutical, Inc. 100.00 2
BMY Bristol-Myers Squibb Company 100.00 2
BMYMP Bristol-Myers Squibb Co 100.00 2
TKPHF Takeda Pharmaceutical Company Limited 100.00 2
VYGR Voyager Therapeutics, Inc. 100.00 2
ETON Eton Pharmaceuticals, Inc. 100.00 2
ORMP Oramed Pharmaceuticals Inc. 100.00 2
STQN Strategic Acquisitions, Inc. 100.00 2
DVLT Datavault AI Inc. 100.00 2
XENE Xenon Pharmaceuticals Inc. 100.00 2
SLNO Soleno Therapeutics, Inc. 100.00 2
ITOCHU ITOCHU 50.00 2
ORANY ORANGE 50.00 2
SPRB Spruce Biosciences, Inc. 50.00 2
SMNR Semnur Pharmaceuticals, Inc. 50.00 2